CONMED
CNMD
156 hedge funds and large institutions have $1.59B invested in CONMED in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 11 closing their positions.
173% more call options, than puts
Call options by funds: $536K | Put options by funds: $196K
73% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 11
16% more capital invested
Capital invested by funds: $1.37B → $1.59B (+$225M)
5% more funds holding
Funds holding: 148 → 156 (+8)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 59
Top Buyers
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$33.9M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$30.3M |
| 3 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$27.7M |
| 4 |
BC
Broadfin Capital
New York
|
-$4.93M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$4.72M |
CNMD Hedge Fund Activity: Q2 2015 in Review
156 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2015, worth a combined $1.59B — up 16% from $1.37B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CNMD positions and 11 closed out — a net gain of 8 holders — while 59 added to existing stakes and 59 trimmed.
The largest buyer was Visium Asset Management, adding an estimated $41.1M. The largest seller was Camber Capital Management, exiting entirely with an estimated $33.9M sold.
- 156 institutional investors held CONMED (CNMD) as of Q2 2015, up from 148 in Q1 2015.
- Funds reported $1.59B of CONMED stock for Q2 2015, up 16% quarter-over-quarter.
- 19 funds opened new CONMED positions in Q2 2015 and 11 closed out, a net change of +8 holders.
- The largest CONMED buyer in Q2 2015 was Visium Asset Management, an estimated $41.1M added.
- The largest CONMED seller in Q2 2015 was Camber Capital Management, an estimated $33.9M sold.
Based on aggregated 13F filings for Q2 2015.